Skipping Cancer: Small Molecule Inhibitors of SKP2-Mediated p27 Degradation

被引：12
|
作者：
Rico-Bautista, Elizabeth [1 ]
Wolf, Dieter A. [1 ]
机构：
[1] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92037 USA
来源：
CHEMISTRY & BIOLOGY | 2012年 / 19卷 / 12期
关键词：
UBIQUITIN LIGASE; ACTIVATION; REVEALS; ENZYME;
D O I：
10.1016/j.chembiol.2012.12.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The cullin-RING ubiquitin ligase, CRL1(SKP2), directing the degradation of the tumor suppressor p27, is a well validated drug target in a wide variety of human cancers. In this issue of Chemistry & Biology, Wu and colleagues describe first-in-class small molecule inhibitors of CRL1(SKP2)-mediated degradation of p27.
引用
收藏
页码：1497 / 1498
页数：2
相关论文
共 50 条
  • [41] Cdc14B/Skp2/p27: a novel cancer axis of evil?
    Coulombe, Philippe
    Rodier, Genevieve
    Meloche, Sylvain
    M S-MEDECINE SCIENCES, 2009, 25 (8-9): : 673 - 675
  • [42] Roles of the Skp2/p27 axis in the progression of chronic nephropathy
    Suzuki, Sayuri
    Ohashi, Naro
    Kitagawa, Masatoshi
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (18) : 3277 - 3287
  • [43] Skp2 inversely correlates with p27 and tuberin in transformed cells
    Rosner, M.
    Hanneder, M.
    Siegel, N.
    Valli, A.
    Fuchs, C.
    Hengstschlaeger, M.
    AMINO ACIDS, 2009, 37 (02) : 257 - 262
  • [44] Expression of p27 and Skp2 in lymphoid hyperplasia and follicular lymphoma
    Ben-Izhak, O
    Trogouboff, P
    Elmalah, I
    Ben-Arieh, Y
    MODERN PATHOLOGY, 2002, 15 (01) : 232A - 232A
  • [45] The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma
    Wang, Jichuan
    Aldahamsheh, Osama
    Ferrena, Alexander
    Borjihan, Hasibagan
    Singla, Amit
    Yaguare, Simon
    Singh, Swapnil
    Viscarret, Valentina
    Tingling, Janet
    Zi, Xiaolin
    Lo, Yungtai
    Gorlick, Richard
    Zheng, Deyou
    Schwartz, Edward L.
    Zhao, Hongling
    Yang, Rui
    Geller, David S.
    Hoang, Bang H.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2021, 1490 (01) : 90 - 104
  • [46] Expression of p27 and Skp2 in lymphoid hyperplasia and follicular lymphoma
    Ben-Izhak, O
    Trogouboff, P
    Elmalah, I
    Ben-Arich, Y
    LABORATORY INVESTIGATION, 2002, 82 (01) : 232A - 232A
  • [47] Roles of the Skp2/p27 axis in the progression of chronic nephropathy
    Sayuri Suzuki
    Naro Ohashi
    Masatoshi Kitagawa
    Cellular and Molecular Life Sciences, 2013, 70 : 3277 - 3287
  • [48] Skp2 inversely correlates with p27 and tuberin in transformed cells
    M. Rosner
    M. Hanneder
    N. Siegel
    A. Valli
    C. Fuchs
    M. Hengstschläger
    Amino Acids, 2009, 37 : 257 - 262
  • [49] p27 is regulated independently of Skp2 in the absence of Cdk2
    Kotoshiba, Shuhei
    Gopinathan, Lakshmi
    Pfeiffenberger, Elisabeth
    Rahim, Anisa
    Vardy, Leah A.
    Nakayama, Keiko
    Nakayama, Keiichi I.
    Kaldis, Philipp
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2014, 1843 (02): : 436 - 445
  • [50] The mTOR inhibitor rapamycin inhibits p27 protein degradation by downregulating the expression of its ubiquitin ligase Skp2 in breast cancer
    Hershko, DD
    Kakiashvili, E
    Rosenberg, Z
    Shapira, M
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (03) : S82 - S83
12345